{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:43:40Z","timestamp":1791323020680,"version":"4.3.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC5x100 and Rete RIN"],"award-info":[{"award-number":["RC5x100 and Rete RIN"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-023-01561-1","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T09:02:32Z","timestamp":1685178152000},"page":"881-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Standards of Fluid Biomarker Collection and Pre-analytical Processes in Humans and Mice: Recommendations by the Ataxia Global Initiative Working Group on Biomarkers"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-9062","authenticated-orcid":false,"given":"Filippo M.","family":"Santorelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4279-2758","authenticated-orcid":false,"given":"Hayley S.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-3993","authenticated-orcid":false,"given":"Justin M.","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-2910","authenticated-orcid":false,"given":"Daniele","family":"Galatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-7273","authenticated-orcid":false,"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-7182","authenticated-orcid":false,"given":"David","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-2202","authenticated-orcid":false,"given":"Puneet","family":"Opal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the AGI-WG2-Biomarkers Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonijevic","family":"Irina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auburger","family":"Georg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bataller","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertini","family":"Enrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boesch","family":"Sylvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boeshore","family":"Samantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buijsen","family":"Ronald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Edwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coarelli","family":"Giulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dupr\u00e9","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durr","family":"Alexandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eigentler","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elert-Dobkowska","family":"Ewelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espinos","family":"Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruq","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fichera","family":"Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fogel","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garces","family":"Pilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graessner","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidari","family":"Morteza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houlden","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcbener-Schmid","family":"Jeannette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jardim","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onodera","family":"Osamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pereira Almeida","family":"de Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primiano","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puccio","family":"H\u00e9l\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosenthal","family":"Liana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacc\u00e0","family":"Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraiva-Pereira Maria","family":"Luiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schmidt","family":"Thorsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sch\u00f6ls","family":"Ludger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvestri","family":"Gabriella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Neta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"issue":"6","key":"1561_CR1","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.29032","volume":"37","author":"T Klockgether","year":"2022","unstructured":"Klockgether T, Ashizawa T, Brais B, Chuang R, Durr A, Fogel B, et al. Paving the way toward meaningful trials in ataxias: an Ataxia Global Initiative Perspective. Mov Disord. 2022;37(6):1125\u201330.","journal-title":"Mov Disord"},{"issue":"12","key":"1561_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jamaneurol.2016.3097","volume":"73","author":"A Didonna","year":"2016","unstructured":"Didonna A, Opal P. Advances in sequencing technologies for understanding hereditary ataxias: a review. JAMA Neurol. 2016;73(12):1485\u201390.","journal-title":"JAMA Neurol"},{"key":"1561_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.15788.1","volume":"7","author":"G Coarelli","year":"2018","unstructured":"Coarelli G, Brice A, Durr A. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view. F1000 Res. 2018;7:1\u201310.","journal-title":"F1000 Res"},{"issue":"9","key":"1561_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","volume":"9","author":"A Durr","year":"2010","unstructured":"Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9(9):885\u201394.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1561_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.neuron.2019.01.049","volume":"101","author":"M Synofzik","year":"2019","unstructured":"Synofzik M, Puccio HM, Mochel F, Schols L. Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies. Neuron. 2019;101(4):560\u201383.","journal-title":"Neuron"},{"key":"1561_CR6","doi-asserted-by":"publisher","first-page":"677551","DOI":"10.3389\/fneur.2021.677551","volume":"12","author":"A Trasch\u00fctz","year":"2021","unstructured":"Trasch\u00fctz A, Reich S, Adarmes AD, Anheim M, Ashrafi MR, Baets J, et al. The ARCA registry: a collaborative global platform for advancing trial readiness in autosomal recessive cerebellar ataxias. Front Neurol. 2021;12:677551.","journal-title":"Front Neurol"},{"key":"1561_CR7","doi-asserted-by":"publisher","first-page":"117417","DOI":"10.1016\/j.jns.2021.117417","volume":"424","author":"ML Chen","year":"2021","unstructured":"Chen ML, Lin CC, Rosenthal LS, Opal P, Kuo SH. Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: implications for therapy development. J Neurol Sci. 2021;424:117417.","journal-title":"J Neurol Sci"},{"issue":"9","key":"1561_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1474-4422(20)30235-0","volume":"19","author":"H Jacobi","year":"2020","unstructured":"Jacobi H, du Montcel ST, Romanzetti S, Harmuth F, Mariotti C, Nanetti L, et al. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study. Lancet Neurol. 2020;19(9):738\u201347.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1561_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/acn3.51370","volume":"8","author":"SM Brooker","year":"2021","unstructured":"Brooker SM, Edamakanti CR, Akasha SM, Kuo SH, Opal P. Spinocerebellar ataxia clinical trials: opportunities and challenges. Ann Clin Transl Neurol. 2021;8(7):1543\u201356.","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"1561_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","volume":"20","author":"DN Cagney","year":"2018","unstructured":"Cagney DN, Sul J, Huang RY, Ligon KL, Wen PY, Alexander BM. The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology. Neuro Oncol. 2018;20(9):1162\u201372.","journal-title":"Neuro Oncol"},{"issue":"5","key":"1561_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-022-02454-z","volume":"144","author":"IE Jansen","year":"2022","unstructured":"Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, et al. Genome-wide meta-analysis for Alzheimer\u2019s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 2022;144(5):821\u201342.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1561_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13195-021-00907-3","volume":"13","author":"T Katayama","year":"2021","unstructured":"Katayama T, Sawada J, Takahashi K, Yahara O, Hasebe N. Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer\u2019s disease, Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer\u2019s Res Ther. 2021;13(1):163.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"9","key":"1561_CR13","doi-asserted-by":"publisher","first-page":"e0274565","DOI":"10.1371\/journal.pone.0274565","volume":"17","author":"L Ning","year":"2022","unstructured":"Ning L, Wang B. Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis. PLoS ONE. 2022;17(9):e0274565.","journal-title":"PLoS ONE"},{"key":"1561_CR14","doi-asserted-by":"publisher","first-page":"712245","DOI":"10.3389\/fneur.2021.712245","volume":"12","author":"YN Zhou","year":"2021","unstructured":"Zhou YN, Chen YH, Dong SQ, Yang WB, Qian T, Liu XN, et al. Role of blood neurofilaments in the prognosis of amyotrophic lateral sclerosis: a meta-analysis. Front Neurol. 2021;12:712245.","journal-title":"Front Neurol"},{"issue":"1","key":"1561_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.28783","volume":"37","author":"L Peng","year":"2022","unstructured":"Peng L, Wang S, Chen Z, Peng Y, Wang C, Long Z, et al. Blood neurofilament light chain in genetic ataxia: a meta-analysis. Mov Disord. 2022;37(1):171\u201381.","journal-title":"Mov Disord"},{"issue":"20","key":"1561_CR16","doi-asserted-by":"publisher","first-page":"e1985","DOI":"10.1212\/WNL.0000000000200257","volume":"98","author":"C Wilke","year":"2022","unstructured":"Wilke C, Mengel D, Sch\u00f6ls L, Hengel H, Rakowicz M, Klockgether T, et al. Levels of neurofilament light at the preataxic and ataxic stages of spinocerebellar ataxia type 1. Neurology. 2022;98(20):e1985\u201396.","journal-title":"Neurology"},{"issue":"7","key":"1561_CR17","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.15252\/emmm.201911803","volume":"12","author":"C Wilke","year":"2020","unstructured":"Wilke C, Haas E, Reetz K, Faber J, Garcia-Moreno H, Santana MM, et al. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice. EMBO Mol Med. 2020;12(7):e11803.","journal-title":"EMBO Mol Med"},{"issue":"8","key":"1561_CR18","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/ene.15373","volume":"29","author":"H Garcia-Moreno","year":"2022","unstructured":"Garcia-Moreno H, Prudencio M, Thomas-Black G, Solanky N, Jansen-West KR, Hanna Al-Shaikh R, et al. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3. Eur J Neurol. 2022;29(8):2439\u201352.","journal-title":"Eur J Neurol"},{"issue":"7","key":"1561_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/biomedicines10071760","volume":"10","author":"D Kon\u00ed\u010dkov\u00e1","year":"2022","unstructured":"Kon\u00ed\u010dkov\u00e1 D, Men\u0161\u00edkov\u00e1 K, Tu\u010dkov\u00e1 L, H\u00e9nykov\u00e1 E, Strnad M, Friedeck\u00fd D, et al. Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status. Biomedicines. 2022;10(7):1760.","journal-title":"Biomedicines"},{"issue":"11","key":"1561_CR20","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/mds.28749","volume":"36","author":"J H\u00fcbener-Schmid","year":"2021","unstructured":"H\u00fcbener-Schmid J, Kuhlbrodt K, Peladan J, Faber J, Santana MM, Hengel H, et al. Polyglutamine-expanded ataxin-3: a target engagement marker for spinocerebellar ataxia type 3 in peripheral blood. Mov Disord. 2021;36(11):2675\u201381.","journal-title":"Mov Disord"},{"key":"1561_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2021.07.018","volume":"89","author":"Y Koike","year":"2021","unstructured":"Koike Y, Jansen-West KR, Hanna Al-Shaikh R, Carlomagno Y, Song Y, Dunmore JA, et al. Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2021;89:151\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1561_CR22","doi-asserted-by":"publisher","first-page":"e12266","DOI":"10.1002\/dad2.12266","volume":"14","author":"EM Jonaitis","year":"2022","unstructured":"Jonaitis EM, Zetterberg H, Koscik RL, Betthauser TJ, Van Hulle CA, Hogan K, et al. Crosswalk study on blood collection-tube types for Alzheimer\u2019s disease biomarkers. Alzheimers Dement (Amst). 2022;14(1):e12266.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"1561_CR23","doi-asserted-by":"publisher","first-page":"e0167969","DOI":"10.1371\/journal.pone.0167969","volume":"12","author":"C Glinge","year":"2017","unstructured":"Glinge C, Clauss S, Boddum K, Jabbari R, Jabbari J, Risgaard B, et al. Stability of circulating blood-based microRNAs-pre-Analytic methodological considerations. PLoS ONE. 2017;12(2):e0167969.","journal-title":"PLoS ONE"},{"issue":"5","key":"1561_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","volume":"11","author":"SE O\u2019Bryant","year":"2015","unstructured":"O\u2019Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research. Alzheimers Dement. 2015;11(5):549\u201360.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"1561_CR25","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/alz.12510","volume":"18","author":"IMW Verberk","year":"2022","unstructured":"Verberk IMW, Misdorp EO, Koelewijn J, Ball AJ, Blennow K, Dage JL, et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease\u2013related blood-based biomarkers: results from the Standardization of Alzheimer\u2019s Blood Biomarkers (SABB) working group. Alzheimers Dement. 2022;18(8):1484\u201397.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1561_CR26","first-page":"137","volume":"22","author":"K Becan-McBride","year":"1999","unstructured":"Becan-McBride K. Laboratory sampling. Does the process affect the outcome? J Intraven Nurs. 1999;22(3):137\u201342.","journal-title":"J Intraven Nurs"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-023-01561-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-023-01561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T08:13:33Z","timestamp":1716020013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-023-01561-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s12311-023-01561-1","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"25 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"FMS, HSM, JMW, DG, MS, DM, and PO declare no competing interests. PO participates in a clinical trial funded by BioHaven Pharmaceuticals and consulted for Reata Pharmaceuticals and UCB Pharmaceuticals. HSM has previously received sponsored research support from Biogen, Lacerta, Roche, and uniQure, and consults for Lacerta Pharmaceuticals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}